Recall events
/
Event 72699
Event summary
Timeline bucket November 11, 2015
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording RemedyRepack Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
7 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 7
Humulin 70/30, 100 Units/mL Inj, Qty: 10 mL Vial, MFG by: Lilly USA, LLC, Indianapolis, IN 46285, Repackaged by: Remedy Repack, Inc, 625 Kolter Dr, Indiana, PA 15701, NDC 52125-0415-08
D-0511-2016
Recall number D-0511-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 65 Vials
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information LOT # B0080702-042715, B0080695-042715, B0097444-082015, Exp 07/2017; B0097443-082015, Exp 02/2018.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9783]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 7
Bicillin L-A 600000 Units/mL Inj., Qty: 20 mL Syringe, MFG by: King Pharma Inc., Bristol, TN 37620, Repackaged by: RemedyRepack, Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0253-03
D-0512-2016
Recall number D-0512-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 60 Vials
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information Lot # B0077329-040215, Exp 07/2017; B0091342-070315, Exp 08/2017; B0109416-102815, Exp 03/2018
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6673]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 7
Vitamin B-Complex 100, Multi MG Inj, Qty: 30 mL Vial, MFG by: Mylan Institutional, Rockford, IL 61103, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 52125-0873-02
D-0513-2016
Recall number D-0513-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 1 Vial
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information Lot # B0105037-100715, Exp 10/01/2016
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8211]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 7
Ascorbic Acid 500 MG/ML Inj., Qty: 50 mL Vial, MFG by: Mylan Institutional, Rockford, IL 61103, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0431-16
D-0514-2016
Recall number D-0514-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 1 Vial
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information LOT # B0105052-100715, Exp 07/01/2017
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6605]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 7
Lorazepam 2 mg/mL Inj., Qty: 1 mL Vial, MFG by: West-Ward Pharma, Eatontown, NJ 07724, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0316-01
D-0515-2016
Recall number D-0515-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 1625 Vials
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information LOT#: B0085124-051915, B0086919-052815, Exp 12/01/2016; B0089280-061215, B0090023-061915, B0089996-061915, B0091581-070715, B0091564-070715, B0091515-070715, Exp 01/01/2017; B0094980-080415, B0094965-080415, B0097515-082415, B0100639-091415, B0100611-091415, Exp 03/01/2017; B0100933-091515, B0107165-101915, B0107118-101915, Exp 06/01/2017.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8218]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 7
Novolin 70/30, 100 Units/mL Solu., Qty: 1 Vial, MFG by: Novo Nordisk, A/S, Bagsvaerd, Denmark DK-2880, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 52125-0414-01
D-0516-2016
Recall number D-0516-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 106 Vials
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information LOT#:QM114CZF0496, Exp 01/2016; B0025373-050514, B0029738-060914, Exp 02/2016; B0029737-060914, Exp 03/2016.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6523]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 7
Rocuronium Bromide 50 MG/5ML INJ., Qty: 5 mL Vial, MFG by: Mylan Institutional, Rockford, IL 61103, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0222-57
D-0517-2016
Recall number D-0517-2016
Initiated November 11, 2015
Classification Class II
Status Terminated
Quantity 4 Vials
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Code information Lot#: B0073852-030915, Exp 04/2016
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9779]
FDA event record
· Exact recall-number query on openFDA
